Cancer Discovery Issues Research Articles in March 2024 Edition
March 19, 2024
March 19, 2024
PHILADELPHIA, Pennsylvania, March 19 -- Cancer Discovery, a peer-reviewed journal from the American Association for Cancer Research that says it describes major advances in research and clinical trials, published research articles on the following topics in its March 2024 edition (Vol. 14, Issue 3):
In the Spotlight:
* A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315
* Targeting the DHX9 RNA Helicase to Induce Antitumor Immunity in Sm . . .
In the Spotlight:
* A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315
* Targeting the DHX9 RNA Helicase to Induce Antitumor Immunity in Sm . . .